CAS: 480-91-1; Isoindolin-1-One

该化合物是一种环流有机化合物,其组成为活性分子,其核心结构为异丁胺酮,由于作为制药和农用化学的建筑块的多功能性,这一脚架对药用和合成化学具有重大兴趣.该复合体的硬性双环框架能够进行精确的结构改变,使其对生物活性分子的设计具有价值.其稳定性和与各种反应条件的兼容性进一步增强了其在多步骤合成物中的效用.研究人员利用2,3-二氢-1H-isoindol-1-one的杠杆作用,开发在...

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号6587-24-2 邻氰基苯甲酸甲酯 | CAS号61864-62-8 2-tert-butyl-3H... | CAS号119-67-5 邻羧基苯甲醛 | CAS号201230-82-2 carbon monoxide | CAS号3959-05-5 邻溴苄胺 | CAS号366453-21-6 4-羟基-异吲哚啉-1-酮 | CAS号96-32-2 溴乙酸甲酯 | CAS号39959-51-8 2-碘苄胺 | CAS号496-12-8 异吲哚啉 | CAS号464-72-2 苯频哪醇 | CAS号82480-87-3 3-(hydroxydiphe... | CAS号675109-26-9 6-溴异吲哚啉-1-酮 | CAS号10017-39-7 2-(胺甲基)苯甲酸盐酸盐 | CAS号110568-64-4 6-硝基-异吲哚啉-1-酮 | CAS号119-39-1 2,3-二氮杂萘酮 | CAS号174392-23-5 (3S)-3-methyl-2... | CAS号25672-97-3 2-(氨甲基)苯甲酸 | CAS号65320-68-5 isoindolo[2,3-b...

合成工艺路线路线简述

    邻羧基苯甲醛置于水,Formamide体系中,化学反应 5.0H,以62%的收率获得产物异吲哚啉-1-酮
    参考文献:无需外部氢即可通过含氧羧酸的环胺化反应轻松反应生成n-(未)取代内酰胺的直接途径
    标题:无需外部氢即可通过含氧羧酸的环胺化反应轻松反应生成n-(未)取代内酰胺的直接途径
    摘要:内酰胺在生物活性天然产物和药物制剂中享有特权,并在功能材料中得到广泛应用.这项研究提出了一种新颖的通用方法,无需催化剂或外部氢就可从含氧羧酸直接合成内酰胺.该方法涉及从水诱导的甲酰胺中原位释放甲酸,以促进有效的环胺化.水还抑制副产物的形成.通过模型实验和密度泛函理论计算的结合阐明了这种非常规途径,其中发现环状亚胺(5-甲基-3,4-二氢-2-吡咯烷酮及其互变异构结构)是形成内酰胺的有利中间体.与包括级联还原胺化和环化的常规方法形成对比.n-未取代和n-取代的内酰胺.
    DOI:10.1002/cssc.201901780

    海关参考信息

    专利信息


    专利号:US-11542269-B2
    优先权日:2018-01-03
    标 题:Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
    发明人:CHOI HYEONG-WOOK; FANG FRANCIS G
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods utilizing Prins reaction in the preparation of compounds that may be useful as intermediates in the synthesis of halichondrin macrolides and analogs thereof. The invention also provides compounds that may be useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.

    专利号:US-10913749-B2
    优先权日:2015-05-07
    标 题 :Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
    发明人:FANG FRANCIS G; KIM DAE-SHIK; CHOI HYEONG-WOOK; CHASE CHARLES E
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods for the synthesis of a halichondrin macrolides through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.

    专利号:US-11136335-B2
    优先权日:2016-06-30
    标题:Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
    发明人:CHASE CHARLES E; CHOI HYEONG-WOOK; ENDO ATSUSHI; FANG FRANCIS G; KIM DAE-SHIK
    权利人:EISAI R&D MAN CO LTD
    摘要:The invention provides methods for the synthesis of a halichondrin macrolides or analogs thereof through a cyclization reaction strategy. The strategy of the present invention involves subjecting an intermediate to Prins reaction conditions to afford a macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides or analogs thereof and methods for preparing the same.

    专利号:US-2006167025-A1
    优先权日:2004-12-22
    标 题:Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs
    发明人:BERGER MARKUS; SCHMEES NORBERT; SCHAECKE HEIKE; BAURLE STEFAN; REHWINKEL HARTMUT; MENGEL ANNE; KROLIKIEWICZ KONRAD; GROSSBACH DANJA; VOIGTLAENDER DAVID
    权利人:BERGER MARKUS; SCHMEES NORBERT; SCHAECKE HEIKE; BAURLE STEFAN; REHWINKEL HARTMUT; MENGEL ANNE; KROLIKIEWICZ KONRAD; GROSSBACH DANJA; VOIGTLAENDER DAVID
    摘要:The invention relates to tricyclic amino alcohols of general formula (I) n nmethod for synthesis of same and use of same as anti-inflammatory agents.

    专利号:US-6159673-A
    优先权日:1996-07-17
    标 题:Oxonol compound, light-sensitive material and process for the synthesis of oxonol compound
    发明人:NISHIGAKI JUNJI; DEGUCHI YASUAKI
    权利人:FUJI PHOTO FILM CO LTD
    摘要:An oxonol compound is represented by the following formula (I): in which Z is an atomic group that forms a cyclic amide ring; each of W1 and W2 independently is an atomic group that forms an acidic nucleus ring; and M is a cation. Other oxonol compounds, a light-sensitive material containing an oxonol compound and a process for the synthesis of an oxonol compound are also disclosed.

    专利号:US-2014255328-A1
    优先权日:2013-03-11
    标 题:Hydrothermal Synthesis of Zinc Phlogopite
    发明人:MCGUIRE MEAGHAN CLARK; BULL IVOR; JOHNSON GEOFFREY MARK
    权利人:BASF SE
    摘要:This invention relates to a synthetically derived zinc phlogopite platelets, of superior platelet diameter, effect pigments comprising such synthetically derived platelets and methods of forming said substrates. More specifically the disclosure describes an improved hydrothermal synthesis of zinc phlogopite suitable as a platelets for interference pigments, barrier and flame retardant applications.
    斯芬克司药物研发(天津)股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sphinxpharm.com
    电话: 022-66211289-843 13672102692👤
    📞斯芬克司药物研发(天津)股份有限公司 ⚠️参考联系方式

    销售电话:022-66211289-843 13672102692
    邮箱:tangjie@sphinxscientificlab.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    安徽实特医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.stepuppharm.com
    电话: 0555-8228058 13621628489👤
    📞安徽实特医药科技有限公司 ⚠️参考联系方式

    销售电话:0555-8228058 13621628489
    邮箱:sales1@stepuppharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/ol201461n
    摘要:Flores B, Molinski TF. Assembly of the isoindolinone core of muironolide A by asymmetric intramolecular Diels-Alder cycloaddition. Org Lett. 2011 Aug 05;13(15):3932–5.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知